Neu-p11 reduces clock/apelin expression in insulin-resistant mouse adipocyte model

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 9, 2013, Pages 798-800

  Li, Xiuping ^a   Cai, Shichang ^a   Yin, Weidong ^b   Hu, Xiaobo ^b  

^a HUAIHUA MEDICAL COLLEGE   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; APLN PROTEIN, MOUSE; CLOCK PROTEIN, MOUSE; GLUCOSE; INDOLE DERIVATIVE; INSULIN; LUZINDOLE; MELATONIN; N (2 (5 METHOXY INDOL 3 YL) ETHYL) 4 OXO 4H PYRAN 2 CARBOXAMIDE; N-(2-(5-METHOXY-INDOL-3-YL)-ETHYL)-4-OXO-4H-PYRAN-2-CARBOXAMIDE; PYRAN DERIVATIVE; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR CLOCK; TRYPTAMINE DERIVATIVE;

ADIPOCYTE; ANIMAL; ARTICLE; CELL STRAIN 3T3; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; INSULIN RESISTANCE; METABOLISM; MOUSE;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CLOCK PROTEINS; GLUCOSE; HYPOGLYCEMIC AGENTS; INDOLES; INSULIN; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MELATONIN; MICE; PYRANS; TRYPTAMINES;

EID: 84883212909     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt077     Document Type: Article

References (11)

1. Kahn SE, Hull RL and Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444: 840-846.
2. Castan-Laurell I, Dray C, Attané C, Duparc T, Knauf C and Valet P. Apelin, diabetes, and obesity. Endocrine 2011, 40: 1-9.
3. Husse J, Hintze SC, Eichele G, Lehnert H and Oster H. Circadian clock genes Per1 and Per2 regulate the response of metabolism-associated transcripts to sleep disruption. PLoS ONE 2012, 7: e52983.
4. Espino J, Pariente JA and Rodríguez AB. Role of melatonin on diabetesrelated metabolic disorders. World J Diabetes 2011, 2: 82-91.
5. Stumpf I, Mühlbauer E and Peschke E. Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic b-cells. J Pineal Res 2008, 45: 318-327.
6. She M, Deng X, Guo Z, Laudon M, Hu Z, Liao D and Hu X, et al. NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats. Pharmacol Res 2009, 59: 248-253.
7. Zhang RX, Jia ZP, Li MX, Guo LM and Zhang XH. The establishment of insulin resistant model in vitro and preliminary application for screening drugs. Chin Pharmacol Bull 2008, 24: 971-976.
8. Li D, Wang GL, Shan MY, Liu JH, Wang L and Zhu DZ. Effects of ursolic acid on c-Cbl-associated protein expression in 3T3-L1adipocytes with insulin resistance. J Chin Integr Med 2012, 10: 886-893.
9. Peschke E, Mühlbauer E, Musshoff U, Csernus VJ, Chankiewitz E and Peschke D. Receptor (MT1) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1. J Pineal Res 2002, 33: 63-71.
10. Kemp DM, Ubeda M and Habener JF. Identification and functional characterization of melatonin Mel 1a receptors in pancreatic b cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling. Mol Cell Endocrinol 2002, 191: 157-166.
11. Zhao WJ, Zhang M, Miao Y, Yang XL and Wang Z. Melatonin potentiates glycine currents through a PLC/PKC signalling pathway in rat retinal ganglion cells. J Physiol 2010, 588: 2605-2619.